Biohaven Ltd.
Current role
BHVN
Kimberly Gentile
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kimberly Gentile
The proxy statement of Biohaven Ltd. reports total compensation of $3,838,971 for Kimberly Gentile in fiscal 2024, including a base salary of $489,306. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Biohaven Ltd. (BHVN)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biohaven Ltd.
Other people whose current roles at this company are on record from its filings.
- Vlad Coric CEO, Board Member
- Matthew Buten CFO
- Warren Volles General Counsel
- Gregory Bailey Board Member
- Irina Antonijevic Board Member
- John Childs Board Member
- John Yetimoglu Board Member
- Julia Gregory Board Member
- Kishan Mehta Board Member
- Michael T. Heffernan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Biohaven Ltd. (BHVN) | Senior Vice President, Clinical Operations | $489,306 | $3,838,971 |
| 2023 | Biohaven Ltd. (BHVN) | Senior Vice President, Clinical Operations | $470,487 | $2,559,873 |
Recent activity
No call appearances or filed executive changes recorded yet.